New generic version of lifesaving fungal drug put to the test
NCT ID NCT06977490
Summary
This study tested if a new, potentially cheaper generic version of a powerful antifungal drug works the same way in the body as the original brand-name version. Healthy volunteers received both versions to compare how the drug is absorbed. The goal is to see if the new version is bioequivalent, meaning it could be a safe and effective alternative for treating serious fungal infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE FUNGAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinan Central Hospital, No.105, Jiefang Road,
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.